Journal of Thrombosis and Haemostasis, 1538-7933

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study

    Alberto Tosetto, Zahra Badiee, Mohammad Reza Baghaipour, Luciano Baronciani, Javier Battle, Erik Berntorp, Imre Bodó, Ulrich Budde, Giancarlo Castaman, Jeroen C.J. Eikenboom, Peyman Eshghi, Cosimo Ettorre, Anne Goodeve, Jenny Goudemand, Charles Richard Morris Hay, Hamid Hoorfar, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W.G. Leebeek & 15 andra, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, Maria Gabriella Mazzucconi, Massimo Morfini, Johannes Oldenburg, Ian Peake, Rafael Parra Lòpez, Flora Peyvandi, Reinhard Schneppenheim, Andreas Tiede, Gholamreza Toogeh, Marc Trossaert, Omidreza Zekavat, Eva M.K. Zetterberg & Augusto B. Federici, 2020 sep 1, I : Journal of Thrombosis and Haemostasis. 18, 9, s. 2145-2154 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta-analysis

    Toshihiko Takada, Sander van Doorn, Sameer Parpia, Kerstin de Wit, David R. Anderson, Scott M. Stevens, Scott C. Woller, Arina J. ten Cate-Hoek, Johan L. Elf, Roderik A. Kraaijenhagen, Roger E.G. Schutgens, Phil S. Wells, Clive Kearon, Karel G.M. Moons & Geert Jan Geersing, 2020 maj 20, I : Journal of Thrombosis and Haemostasis.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays

    Andreas Hillarp, Karin Strandberg, Kerstin M. Gustafsson & Tomas L. Lindahl, 2020 apr 15, I : Journal of Thrombosis and Haemostasis.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Detection of F8 int22h inversions using digital droplet PCR and mile-post assays

    Eric Manderstedt, Christina Lind-Halldén, Rolf Ljung, Jan Astermark & Christer Halldén, 2020 feb 7, I : Journal of Thrombosis and Haemostasis.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2019
  7. New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short

    Björn Dahlbäck, Li Jun Guo, Bengt Zöller & Sinh Tran, 2019, I : Journal of Thrombosis and Haemostasis. 17, 4, s. 585-595

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2018
  9. Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity

    M. Olsson, T. M. Stanne, A. Pedersen, E. Lorentzen, E. Kara, A. Martinez-Palacian, N. P. Rønnow Sand, A. F. Jacobsen, P. M. Sandset, J. J. Sidelmann, G. Engström, O. Melander, S. M. Kanse & C. Jern, 2018, I : Journal of Thrombosis and Haemostasis. 16, 10, s. 2024-2034

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. 2017
  11. Effect of late prophylaxis in hemophilia on joint status: A randomized trial

    M. J. Manco-Johnson, B. Lundin, S. Funk, C Peterfy, D. Raunig, M. Werk, C L Kempton, M. T Reding, S. Goranov, L. Gercheva, L Rusen, M. V. Uscatescu, Marina Pierdominici, S. Engelen, J. Pocoski, D. Walker & W Hong, 2017 nov, I : Journal of Thrombosis and Haemostasis. 15, 11, s. 2115-2124

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: Results of the INSIGHT case-control study

    Alice S. van Velzen, C. L. Eckhardt, M. Peters, F. W. G. Leebeek, C. Escuriola-Ettingshausen, C Hermans, Russell D. Keenan, J. Astermark, Christoph Male, K Peerlinck, Saskia le Cessie, J. G. Van der Bom & K. Fijnvandraat, 2017 jul 3, I : Journal of Thrombosis and Haemostasis. 15, 7, s. 1422-1429

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S

    B. Dahlbäck, 2017 jul 1, I : Journal of Thrombosis and Haemostasis. 15, 7, s. 1241-1250 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2016
  15. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: A two-center study

    A. E. Bowyer, A. Hillarp, M. Ezban, P. Persson & S. Kitchen, 2016, I : Journal of Thrombosis and Haemostasis. 14, 7, s. 1428-1435

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.

    Ari Brekkan, Erik Berntorp, Kirsten Jensen, Elisabet I Nielsen & Siv Jönsson, 2016, I : Journal of Thrombosis and Haemostasis. 14, 4, s. 724-732

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.

    R Tuckuviene, S Ranta, B K Albertsen, N G Andersson, M D Bendtsen, T Frisk, M W Gunnes, J Helgestad, M M Heyman, O G Jonsson, A Mäkipernaa, K Pruunsild, Ulf Tedgård, S S Trakymiene & E Ruud, 2016, I : Journal of Thrombosis and Haemostasis. 14, 3, s. 485-494

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.

    Huda Kozarcanin, Christian Lood, Lea Munthe-Fog, Kerstin Sandholm, Osama A Hamad, Anders Bengtsson, Mikkel-Ole Skjoedt, Markus Huber-Lang, Peter Garred, Kristina N Ekdahl & Bo Nilsson, 2016, I : Journal of Thrombosis and Haemostasis. 14, 3, s. 531-545

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. 2015
  20. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.

    Kenny M Hansson, David Gustafsson, Tor Skärby, Lars Frison & Erik Berntorp, 2015, I : Journal of Thrombosis and Haemostasis. 13, 7, s. 1293-1300

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

    T Abshire, J Cox-Gill, C L Kempton, F W G Leebeek, M Carcao, P Kouides, S Donfield & Erik Berntorp, 2015, I : Journal of Thrombosis and Haemostasis. 13, 9, s. 1585-1589

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 2014
  23. Definitions in hemophilia: communication from the SSC of the ISTH

    V. S. Blanchette, N. S. Key, Rolf Ljung, M. J. Manco-Johnson, H. M. Van Den Berg & A. Srivastava, 2014, I : Journal of Thrombosis and Haemostasis. 12, 11, s. 1935-1939

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.

    Andreas Hillarp, Kerstin M Gustafsson, Lars Faxälv, Karin Strandberg, Fariba Baghaei, Inger Fagerberg Blixter, Maria Berndtsson & Tomas L Lindahl, 2014, I : Journal of Thrombosis and Haemostasis. 12, 9, s. 1545-1553

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma

    M. Hultcrantz, R. M. Pfeiffer, M. Bjorkholm, L. R. Goldin, Ingemar Turesson, S. Schulman, O. Landgren & S. Y. Kristinsson, 2014, I : Journal of Thrombosis and Haemostasis. 12, 11, s. 1816-1821

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

    C. L. Eckhardt, Jan Astermark, S. Q. Nagelkerke, J. Geissler, M. W. T. Tanck, M. Peters, K. Fijnvandraat & T. W. Kuijpers, 2014, I : Journal of Thrombosis and Haemostasis. 12, 8, s. 1294-1301

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2013
  28. 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.

    Rolf Ljung, F A Karim, K Saxena, Toru Suzuki, P Arkhammar, A Rosholm & P Giangrande, 2013, I : Journal of Thrombosis and Haemostasis. 11, 7, s. 1260-1268

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Origin of Swedish hemophilia B mutations

    C. Hallden, Annika Mårtensson, D. Nilsson, Torbjörn Säll, C. Lind-Hallden, A. C. Liden & Rolf Ljung, 2013, I : Journal of Thrombosis and Haemostasis. 11, 11, s. 2001-2008

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.

    Milladur Rahman, Songen Zhang, Michelle Chew, Ingvar Syk, Bengt Jeppsson & Henrik Thorlacius, 2013, I : Journal of Thrombosis and Haemostasis. 11, 7, s. 1385-1398

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. 2012
  32. Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry.

    P Knoebl, M Paese, F Baudo, P Collins, A Huth-Kühne, L Nemes, F Pellegrini, Lilian Tengborn & H Lévesque, 2012, I : Journal of Thrombosis and Haemostasis. 10, 4, s. 622-631

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

    C A Clark, R Vatsyayan, Ulla Hedner, C T Esmon, U R Pendurthi & L V M Rao, 2012, I : Journal of Thrombosis and Haemostasis. 10, 11, s. 2383-2391

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?

    C. Hermans, Jan Astermark & P. De Moerloos, 2012, I : Journal of Thrombosis and Haemostasis. 10, 10, s. 2194-2196

    Forskningsoutput: TidskriftsbidragLetter

  35. Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.

    S Y Kristinsson, L Goldin, Ingemar Turesson, M Hultcrantz, M Björkholm & O Landgren, 2012, I : Journal of Thrombosis and Haemostasis. 10, 5, s. 962-964

    Forskningsoutput: TidskriftsbidragLetter

  36. Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.

    R Gopalakrishnan, U R Pendurthi, Ulla Hedner, H Agersø, C T Esmon & L V M Rao, 2012, I : Journal of Thrombosis and Haemostasis. 10, 5, s. 971-973

    Forskningsoutput: TidskriftsbidragLetter

  37. Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).

    I Pabinger, C Y Vossen, J Lang, J Conard, M C García-Dabrio, W Miesbach, C Legnani, Peter Svensson, A Kaider & F R Rosendaal, 2012, I : Journal of Thrombosis and Haemostasis. 10, 2, s. 217-222

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Origin of Swedish hemophilia A mutations

    C. Halldén, D. Nilsson, Torbjörn Säll, C. Lind-Hallden, A. C. Liden & Rolf Ljung, 2012, I : Journal of Thrombosis and Haemostasis. 10, 12, s. 2503-2511

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.

    P W Collins, J Møss, Karin Knobe, A Groth, T Colberg & E Watson, 2012, I : Journal of Thrombosis and Haemostasis. 10, 11, s. 2305-2312

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. 2011
  41. Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden

    R. Ljung & ANNIKA MÅRTENSSON, 2011 jul 1, I : Journal of Thrombosis and Haemostasis. 9, s. 462 1 s., P-TU-492.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  42. A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).

    A Gringeri, Björn Lundin, S V Mackensen, L Mantovani & P M Mannucci, 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 700-710

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.

    Andreas Hillarp, F Baghaei, I F Blixter, K M Gustafsson, L Stigendal, M Sten-Linder, Karin Strandberg & T L Lindahl, 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 133-139

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.

    G M A van Os, J C M Meijers, C Ağar, M Valls Serón, J A Marquart, Per Åkesson, R T Urbanus, R H W M Derksen, Heiko Herwald, Matthias Mörgelin & P G de Groot, 2011, I : Journal of Thrombosis and Haemostasis. 9, 12, s. 2447-2456

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.

    H Agersø, D F Brophy, H Pelzer, E J Martin, M Carr, Ulla Hedner & M Ezban, 2011, I : Journal of Thrombosis and Haemostasis. 9, 2, s. 333-338

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).

    A Tiede, Ute Friedrich, C Stenmo, G Allen, P Giangrande, J Goudemand, C Hay, Eva M Holmström, R Klamroth, Stefan Lethagen, S McKenzie, W Miesbach, C Negrier, V J Yuste & Erik Berntorp, 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 1191-1199

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.

    Carl Högberg, Olof Gidlöf, Chanyuan Tan, Siv Svensson, Jenny Öhman, David Erlinge & Björn Olde, 2011, I : Journal of Thrombosis and Haemostasis. 9, 2, s. 361-372

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Wide temperature range testing with sonoclot plateletfunction and ROTEM EXTEM/FIBTEM/APTEM test

    Ulf Schött, Jens Brokopp, Jan Mårtensson, Attila Frigyesi & Hans Friberg, 2011, I : Journal of Thrombosis and Haemostasis. 9, s2, s. 91 1 s., P-MO-104.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  49. 2010
  50. APC-PCI complex as new tool for the evaluation of anticoagulant response to endogenous thrombin formation and its sequel in fibrinolysis

    C. Kluft, Johan Stenflo, P. Meijer & J. Burggraaf, 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 58-58

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  51. Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

    Valls M. Seron, P. F. Marx, J. A. Marquart, Heiko Herwald, P. G. de Groot & J. C. M. Meijers, 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 20-21

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  52. Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)

    R. Gopalakrishnan, Ulla Hedner, S. Ghosh, R. C. Nayak, T. C. Allen, U. R. Pendurthi & L. V. M. Rao, 2010, I : Journal of Thrombosis and Haemostasis. 8, 2, s. 301-310

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.

    Carl Ekman, Jonas Stenhoff & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, 4, s. 838-844

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.

    Andreas Hillarp, M Stadler, C Haderer, J Weinberger, C M Kessler & J Römisch, 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 2216-2223

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Novel APC-cleavage sites in FVa providing insights into mechanisms of action of APC and its cofactor protein S.

    Sinh Tran & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, 1, s. 129-136 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. rFVIIa transported from the blood stream into tissues is functionally active

    R. Gopalakrishnan, Ulla Hedner, C. Clark, U. R. Pendurthi & L. V. M. Rao, 2010, I : Journal of Thrombosis and Haemostasis. 8, 10, s. 2318-2321

    Forskningsoutput: TidskriftsbidragLetter

  57. The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.

    Cecilia Oslakovic, M Jauhiainen, C Ehnholm & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 766-772

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  58. 2009
  59. An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and aPTT

    Ulf Schött, Malin Rundgren & M Engström, 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 871-872 PP-WE-721.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  60. Autologous plasma for the study of anaphylatoxinkinetics in man

    Ulf Schött & Rut Norda, 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, PP-MO-672.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  61. Bedside point of care coagulation testing forindividualized antivitamin K reversal in emergencysurgery

    Ulf Schött, D. Winstedt & P Anveden, 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 1167 1 s., PP-TH-695.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  62. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

    P. W. Collins, V. S. Blanchette, K. Fischer, S. Bjorkman, M. Oh, S. Fritsch, P. Schroth, G. Spotts, Jan Astermark & B. Ewenstein, 2009, I : Journal of Thrombosis and Haemostasis. 7, 3, s. 413-420

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  63. Can proteins induced by vitamin K absence - PIVKA-II - detect subclinical vitamin k deficit in major surgery?

    Ulf Schött, P Anveden, Karin Strandberg, Per Flisberg, M Engström & Andreas Hillarp, 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 404 PP-MO-258.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  64. Comparison of two different heparin doses inperipheral vascular surgery

    Ulf Schött & DAG WINSTEDT, 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, PP-TH-359.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  65. Comparison of two infusionrates of antithrombinconcentrate in cardiopulmonary bypass surgery

    Ulf Schött, Tony Carlsson & Philip Lund, 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 1075 1 s., PP-TH-428.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  66. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis

    P. G. Lindqvist, Elisabeth Epstein & Håkan Olsson, 2009, I : Journal of Thrombosis and Haemostasis. 7, 4, s. 605-610

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  67. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A

    A. Pavlova, D. Delev, S. Lacroix-Desmazes, R. Schwaab, M. Mende, R. Fimmers, Jan Astermark & J. Oldenburg, 2009, I : Journal of Thrombosis and Haemostasis. 7, 12, s. 2006-2015

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  68. Prothrombin complex concentrate and effects on thecone and plate analyser

    Ulf Schött, Lena Jirgård, Karin Strandberg & Andreas Hillarp, 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 885 1 s., PP-WE-758.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  69. The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?

    P. F. Marx, T. Plug, S. R. Havik, Matthias Mörgelin & J. C. M. Meijers, 2009, I : Journal of Thrombosis and Haemostasis. 7, 3, s. 445-452

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  70. 2008
  71. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

    U Budde, R Schneppenheim, J Eikenboom, A Goodeve, K Will, E Drewke, G Castaman, F Rodeghiero, A B Federici, J Batlle, A Perez, D Meyer, C Mazurier, J Goudemand, J Ingerslev, D Habart, Z Vorlova, Lars Holmberg, Stefan Lethagen, J Pasi & 2 andra, F Hill & I Peake, 2008, I : Journal of Thrombosis and Haemostasis. 6, 5, s. 762-771

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  72. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats

    B Lauritzen, Ulla Hedner, P B Johansen, M Tranholm & M Ezban, 2008, I : Journal of Thrombosis and Haemostasis. 6, 5, s. 804-811

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  73. 2007
  74. An immunochemical method for quantitative determination of latent antithrombin, the reactive center loop-inserted uncleaved form of antithrombin.

    Margareta Kjellberg, Berit Rimac & Johan Stenflo, 2007, I : Journal of Thrombosis and Haemostasis. 5, s. 127-132

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  75. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)

    A. Tosetto, F. Rodeghiero, G. Castaman, M. Bernardi, K. Bertoncello, A. Goodeve, A. B. Federici, J. Batlle, D. Meyer, C. Mazurier, J. Goudemand, J. Eikenboom, R. Schneppenheim, U. Budde, J. Ingerslev, Z. Vorlova, D. Habart, Lars Holmberg, Stefan Lethagen, J. Pasi & 2 andra, F. Hill & I. Peake, 2007, I : Journal of Thrombosis and Haemostasis. 5, 4, s. 715-721

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  76. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A

    Jan Astermark, X. Wang, J. Oldenburg, Erik Berntorp & A. -K. Lefvert, 2007, I : Journal of Thrombosis and Haemostasis. 5, 2, s. 263-265

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  77. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice

    Annika Jögi, J Pass, G Hoyer-Hansen, L R Lund, B S Nielsen, K Dano & J Romer, 2007, I : Journal of Thrombosis and Haemostasis. 5, 9, s. 1936-1944

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  78. Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients

    A. Borel-Derlon, A. B. Federici, V. Roussel-Robert, J. Goudemand, C. A. Lee, I. Scharrer, C. Rothschild, Erik Berntorp, C. Henriet, Z. Tellier, F. Bridey & P. M. Mannucci, 2007, I : Journal of Thrombosis and Haemostasis. 5, 6, s. 1115-1124

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  79. Von Willebrand factor/factor VIII concentrate (Haemate(R) P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.

    Stefan Lethagen, P A Kyrle, G Castaman, S Haertel & P M Mannucci, 2007, I : Journal of Thrombosis and Haemostasis. 5, Apr 16, s. 1420-1430

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  80. 2006
  81. Activated protein C resistance - in the absence of factor V Leiden - and pregnancy.

    P G Lindqvist, P Svensson & Björn Dahlbäck, 2006, I : Journal of Thrombosis and Haemostasis. 4, 2, s. 361-366

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  82. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)

    A Tosetto, F Rodeghiero, G Castaman, A Goodeve, AB Federici, J Batlle, D Meyer, E Fressinaud, C Mazurier, J Goudemand, J Eikenboom, R Schneppenheim, U Budde, J Ingerslev, Z Vorlova, D Habart, Lars Holmberg, Stefan Lethagen, J Pasi, F Hill & 1 andra, I Peake, 2006, I : Journal of Thrombosis and Haemostasis. 4, 4, s. 766-773

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  83. Are randomized clinical trials the only truth? Not always

    L Aledort, Rolf Ljung & V Blanchette, 2006, I : Journal of Thrombosis and Haemostasis. 4, 3, s. 503-504

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  84. Family secrets to be disclosed.

    P G Lindqvist & Joyce Carlson, 2006, I : Journal of Thrombosis and Haemostasis. 4, 10, s. 2180-2181

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  85. From gamma-carboxy-glutamate to protein C.

    Johan Stenflo, 2006, I : Journal of Thrombosis and Haemostasis. 4, 12, s. 2521-2526

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  86. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study

    G. Castaman, F. Rodeghiero, A. Tosetto, A. Cappelletti, F. Baudo, J. C. J. Eikenboom, A. B. Federici, Stefan Lethagen, S. Linari, J. Lusher, M. Nishino, P. Petrini, A. Srivastava & J. S. Ungerstedt, 2006, I : Journal of Thrombosis and Haemostasis. 4, 10, s. 2164-2169

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  87. Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23 796 consecutive autopsies

    A. Eliasson, D. Bergqvist, M. Bjorck, Stefan Acosta, Nils Sternby & M. Ogren, 2006, I : Journal of Thrombosis and Haemostasis. 4, 9, s. 1897-1902

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  88. Influence of endotoxin challenge on protein S and C4b-binding protein in healthy subjects

    KS Krabbe, H Bruunsgaard, Andreas Hillarp & S Thorsen, 2006, I : Journal of Thrombosis and Haemostasis. 4, 3, s. 692-694

    Forskningsoutput: TidskriftsbidragLetter

  89. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

    J Eikenboom, V Van Marion, H Putter, A Goodeve, F Rodeghiero, G Castaman, AB Federici, J Batlle, D Meyer, C Mazurier, J Goudemand, R Schneppenheim, U Budde, J Ingerslev, Z Vorlova, D Habart, Lars Holmberg, S Lethagen, J Pasi, F Hill & 1 andra, I Peake, 2006, I : Journal of Thrombosis and Haemostasis. 4, 4, s. 774-782

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  90. Potential role of rFVIIa in prophylaxis in severe haemophilia patients with inhibitors.

    Ulla Hedner, 2006, I : Journal of Thrombosis and Haemostasis. 4, Aug 14, s. 2498-2500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  91. The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin.

    Margareta Kjellberg, Teresa Ikonomou & Johan Stenflo, 2006, I : Journal of Thrombosis and Haemostasis. 4, 1, s. 168-176

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  92. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis

    M. Van de Wouwer, S. Plaisance, A. De Vriese, E. Waelkens, D. Collen, Jenny J Persson, M. R. Daha & E. M. Conway, 2006, I : Journal of Thrombosis and Haemostasis. 4, 8, s. 1813-1824

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  93. The natural course of women with recurrent fetal loss

    Pelle Lindqvist & Juan Merlo, 2006, I : Journal of Thrombosis and Haemostasis. 4, 4, s. 896-7

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  94. The von Willebrand disease prophylaxis network: exploring a treatment concept.

    Erik Berntorp & T Abshire, 2006, I : Journal of Thrombosis and Haemostasis. 4, 11, s. 2511-2512

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  95. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

    J. E. Sadler, U. Budde, J. C. J. Eikenboom, E. J. Favaloro, F. G. H. Hill, Lars Holmberg, J. Ingerslev, C. A. Lee, D. Lillicrap, M. Mannucci, C. Mazurier, D. Meyer, W. L. Nichols, M. Nishino, I. R. Peake, F. Rodeghiero, R. Schneppenheim, Z. M. Ruggeri, A. Srivastava, R. R. Montgomery & 1 andra, A. B. Federici, 2006, I : Journal of Thrombosis and Haemostasis. 4, 10, s. 2103-2114

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  96. 2005
  97. Factor H binds to washed human platelets.

    F Vaziri-Sani, J Hellwage, P F Zipfel, Anders Sjöholm, Ruxandra Iancu & Diana Karpman, 2005, I : Journal of Thrombosis and Haemostasis. 3, 1, s. 154-162

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  98. Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype.

    Elsa Lanke, Anna Johansson, Christer Halldén & Stefan Lethagen, 2005, I : Journal of Thrombosis and Haemostasis. 3, 12, s. 2656-2663

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  99. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination - a rebuttal

    N Egberg, I Fagerberg, Andreas Hillarp, TL Lindahl & L Stigendal, 2005, I : Journal of Thrombosis and Haemostasis. 3, 10, s. 2370-2371

    Forskningsoutput: TidskriftsbidragLetter

  100. Pharmacokinetic studies on Wilfactin((R)), a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods

    J Goudemand, I Scharrer, Erik Berntorp, CA Lee, A Borel-Derlon, N Stieltjes, C Caron, JM Scherrmann, F Bridey, Z Tellier, AB Federici & PM Mannucci, 2005, I : Journal of Thrombosis and Haemostasis. 3, 10, s. 2219-2227

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  101. Post-translational modifications in proteins involved in blood coagulation.

    Karin M Hansson & Johan Stenflo, 2005, I : Journal of Thrombosis and Haemostasis. 3, 12, s. 2633-2648

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  102. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

    CY Vossen, J Conard, J Fontcuberta, M Makris, FJM Van der Meer, I Pabinger, G Palareti, FE Preston, I Scharrer, JC Souto, Peter Svensson, ID Walker & FR Rosendaal, 2005, I : Journal of Thrombosis and Haemostasis. 3, 3, s. 459-464

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  103. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma.

    Ann-Kristin Öhlin, Kerstin Larsson & Maria Hansson, 2005, I : Journal of Thrombosis and Haemostasis. 3, 5, s. 976-982

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  104. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study

    F Rodeghiero, G Castaman, A Tosetto, J Batlle, F Baudo, A Cappelletti, P Casana, N De Bosch, JCJ Eikenboom, AB Federici, Stefan Lethagen, S Linari & A Srivastava, 2005, I : Journal of Thrombosis and Haemostasis. 3, 12, s. 2619-2626

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  105. 2004
  106. Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1.

    Elsa Lanke, Anna Johansson, Andreas Hillarp, Stefan Lethagen, Bengt Zöller, Björn Dahlbäck & Christer Halldén, 2004, I : Journal of Thrombosis and Haemostasis. 2, 11, s. 1918-1923

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  107. Familial thrombophilia and lifetime risk of venous thrombosis

    CY Vossen, J Conard, J Fontcuberta, M Makris, FJM Van Der Meer, I Pabinger, G Palareti, FE Preston, I Scharrer, JC Souto, Peter Svensson, ID Walker & FR Rosendaal, 2004, I : Journal of Thrombosis and Haemostasis. 2, 9, s. 1526-1532

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  108. Hereditary thrombophilia and fetal loss: a prospective follow-up study

    CY Vossen, FE Preston, J Conard, J Fontcuberta, M Makris, FJM Van Der Meer, I Pabinger, G Palareti, I Scharrer, JC Souto, Peter Svensson, ID Walker & FR Rosendaal, 2004, I : Journal of Thrombosis and Haemostasis. 2, 4, s. 592-596

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  109. The multiple faces of the partial thromboplastin time APTT.

    Björn Dahlbäck, 2004, I : Journal of Thrombosis and Haemostasis. 2, 12, s. 2256-2257

    Forskningsoutput: TidskriftsbidragLetter

  110. Transcriptional down-regulation of the platelet ADP receptor P2Y(12) and clusterin in patients with systemic lupus erythematosus.

    Lingwei Wang, P Erling, Anders Bengtsson, Lennart Truedsson, Gunnar Sturfelt & David Erlinge, 2004, I : Journal of Thrombosis and Haemostasis. 2, 8, s. 1436-1442

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  111. 2003
  112. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding

    E Ajzner, I Balogh, G Haramura, Z Boda, K Kalmar, G Pfliegler, Björn Dahlbäck & L Muszbek, 2003, I : Journal of Thrombosis and Haemostasis. 1, 5, s. 943-949

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift